Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 13/20 | 0.51 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
| ▸ | BHMT | Q93088 | 1/20 | 0.44 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.44 |
| ▸ | GRM8 | O00222 | 1/20 | 0.42 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.42 |
| ▸ | KYNU | Q16719 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Racemethionine SCHEMBL14248767 | 1.00 | KIF11 (0.51) | KIF11SLC7A5ALPIPKMPTGS1 | |
| Methionine SCHEMBL14248751 | 0.89 | KIF11 (0.52) | KIF11KYNU | |
| Racemethionine SCHEMBL14248750 | 0.89 | KIF11 (0.52) | KIF11KYNU | |
| Racemethionine SCHEMBL27686953 | 0.88 | BHMT (0.53) | BHMTBHMT2GRM8GRM4 | |
| Racemethionine SCHEMBL28117612 | 0.87 | KIF11 (0.54) | KIF11SLC7A5ALPIPKMPTGS1 | |
| Methionine SCHEMBL28117610 | 0.87 | KIF11 (0.54) | KIF11SLC7A5ALPIPKMPTGS1 | |
| Racemethionine SCHEMBL28833032 | 0.85 | KIF11 (0.48) | KIF11SLC7A5ALPIPKMPTGS1 | |
| Tyrosine SCHEMBL180585 | 0.84 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| Racemethionine SCHEMBL3361637 | 0.84 | BHMT (0.47) | KIF11BHMTBHMT2 | |
| Racemethionine SCHEMBL526136 | 0.84 | ALPI (0.50) | KIF11SLC7A5ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3419595-A1 | STABLE LIQUID GONADOTROPIN FORMULATION | Ferring B.V. (NL) | 2019-01-02 | — | — | EP | disclosed |
| WO-2017144659-A1 | STABLE LIQUID GONADOTROPIN FORMULATION | FERRING B.V. (NL) | 2017-08-31 | — | — | WO | disclosed |
| EP-2720712-A2 | STABLE FORMULATIONS OF A HYALURONAN-DEGRADING ENZYME | Halozyme, Inc. (US) | 2014-04-23 | — | — | EP | disclosed |
| WO-2012174478-A9 | STABLE FORMULATIONS OF A HYALURONAN-DEGRADING ENZYME | HALOZYME, INC. (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2012174478-A2 | STABLE FORMULATIONS OF A HYALURONAN-DEGRADING ENZYME | HALOZYME, INC. (US) | 2012-12-20 | — | — | WO | disclosed |